CN101417086A - Traditional Chinese medicine preparation for treating myocardial ischemia - Google Patents
Traditional Chinese medicine preparation for treating myocardial ischemia Download PDFInfo
- Publication number
- CN101417086A CN101417086A CNA2008101798634A CN200810179863A CN101417086A CN 101417086 A CN101417086 A CN 101417086A CN A2008101798634 A CNA2008101798634 A CN A2008101798634A CN 200810179863 A CN200810179863 A CN 200810179863A CN 101417086 A CN101417086 A CN 101417086A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 76
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 208000031225 myocardial ischemia Diseases 0.000 title claims abstract description 30
- 241000555712 Forsythia Species 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 241000219780 Pueraria Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 239000006187 pill Substances 0.000 claims description 8
- 108010052008 colla corii asini Proteins 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000167550 Centella Species 0.000 claims 4
- 241000545442 Radix Species 0.000 claims 4
- 241000189524 Baccharis halimifolia Species 0.000 claims 1
- 235000012907 honey Nutrition 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 229940079593 drug Drugs 0.000 abstract description 25
- 240000001341 Reynoutria japonica Species 0.000 abstract description 16
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract description 16
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 15
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 15
- 229940010454 licorice Drugs 0.000 abstract description 15
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract description 12
- 241000405911 Rehmannia glutinosa Species 0.000 abstract description 12
- 235000017803 cinnamon Nutrition 0.000 abstract description 12
- 241000208688 Eucommia Species 0.000 abstract description 11
- 241001289529 Fallopia multiflora Species 0.000 abstract description 11
- 108010010803 Gelatin Proteins 0.000 abstract description 11
- 229920000159 gelatin Polymers 0.000 abstract description 11
- 239000008273 gelatin Substances 0.000 abstract description 11
- 235000019322 gelatine Nutrition 0.000 abstract description 11
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 11
- 241001061264 Astragalus Species 0.000 abstract description 10
- 241000092665 Atractylodes macrocephala Species 0.000 abstract description 10
- 244000146462 Centella asiatica Species 0.000 abstract description 10
- 235000004032 Centella asiatica Nutrition 0.000 abstract description 10
- 235000006533 astragalus Nutrition 0.000 abstract description 10
- 210000004233 talus Anatomy 0.000 abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 9
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 8
- 244000197580 Poria cocos Species 0.000 abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 7
- 244000046146 Pueraria lobata Species 0.000 abstract description 5
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 5
- 244000061520 Angelica archangelica Species 0.000 abstract description 3
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 230000001419 dependent effect Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000007059 acute toxicity Effects 0.000 abstract description 2
- 231100000403 acute toxicity Toxicity 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 45
- 239000008280 blood Substances 0.000 description 45
- 208000002193 Pain Diseases 0.000 description 28
- 210000002216 heart Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 17
- 241000202807 Glycyrrhiza Species 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 108091006146 Channels Proteins 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 8
- 241000305491 Gastrodia elata Species 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 8
- 244000132619 red sage Species 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 241000132012 Atractylodes Species 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 208000023589 ischemic disease Diseases 0.000 description 7
- 230000002107 myocardial effect Effects 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000125175 Angelica Species 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 235000017276 Salvia Nutrition 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 231100000517 death Toxicity 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010008469 Chest discomfort Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241001072909 Salvia Species 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 241000382455 Angelica sinensis Species 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 230000000004 hemodynamic effect Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940124579 cold medicine Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
- 229960005205 prednisolone Drugs 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- ZZPQSQFQHIGCRC-OOFFSTKBSA-N (2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-c Chemical compound [Zn].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ZZPQSQFQHIGCRC-OOFFSTKBSA-N 0.000 description 1
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 230000005971 DNA damage repair Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 239000009524 danshen dripping Substances 0.000 description 1
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940119740 deoxycorticosterone Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- -1 isoflavone compound Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗心肌缺血的中药制剂,各种成分的重量份数比为:杜仲10~20份、羌活10~20份、葛根10~20份、丹参10~20份、当归10~20份、天麻10~20份、黄芪10~20份、虎杖10~20份、积雪草10~20份、川芎10~20份、茯苓10~20份、肉桂10~20份、白术10~20份、连翘10~20份、熟地10~20份、何首乌10~20份、阿胶10~20份、甘草10~20份。本发明治疗心肌缺血的中药制剂使用安全,无毒性,经急毒实验验证,无毒副作用,适用于不同体质的患者,可长期服用;本发明治疗心肌缺血的中药制剂无耐药性,无有依赖性的药物成分,因此病人长期服用也不会产生依赖性。The invention discloses a traditional Chinese medicine preparation for treating myocardial ischemia. The weight-to-number ratios of various components are as follows: 10-20 parts of Eucommia, 10-20 parts of notopterygium, 10-20 parts of kudzu root, 10-20 parts of salvia miltiorrhiza, and 10 parts of angelica ~20 parts, Gastrodia 10~20 parts, Astragalus 10~20 parts, Polygonum cuspidatum 10~20 parts, Centella asiatica 10~20 parts, Chuanxiong 10~20 parts, Poria cocos 10~20 parts, cinnamon 10~20 parts, Atractylodes macrocephala 10 parts ~20 parts, 10~20 parts of forsythia, 10~20 parts of Rehmannia glutinosa, 10~20 parts of Polygonum multiflorum, 10~20 parts of donkey-hide gelatin, 10~20 parts of licorice. The traditional Chinese medicine preparation for treating myocardial ischemia of the present invention is safe to use, non-toxic, verified by acute toxicity experiments, has no toxic and side effects, is suitable for patients with different constitutions, and can be taken for a long time; the traditional Chinese medicine preparation for treating myocardial ischemia of the present invention has no drug resistance, There are no dependent drug ingredients, so patients will not be dependent on long-term use.
Description
技术领域 technical field
本发明涉及含有来源于植物、动物或矿物原料的医用配制品,特别涉及一种治疗心肌缺血的中药制剂。The invention relates to a medical preparation containing raw materials derived from plants, animals or minerals, in particular to a traditional Chinese medicine preparation for treating myocardial ischemia.
背景技术 Background technique
心肌缺血性疾病是一种常见的疾病,多发于中老年人群中,也是暂时丧失劳动能力以及具有劳动能力的人过早残废最常见的原因。其基本症状为心前区不适,隐痛,心慌,气急,胸闷,神疲易倦,周身肌肉酸痛,心律不齐等。中医学认为该病与心血亏损、气虚血瘀、邪热扰心有关。美国每年约有50万人死于本病,占本病人数1/3-1/2,占心脏病死亡人数的50-70%。我国发病率约在30%,占死亡人数的40%以上,且逐年增高,现已成为导致人口死亡的主要原因。Myocardial ischemic disease is a common disease, mostly in middle-aged and elderly people, and it is also the most common cause of temporary loss of working ability and premature disability of people with working ability. The basic symptoms are precordial discomfort, dull pain, palpitation, shortness of breath, chest tightness, fatigue and easy tiredness, muscle aches all over the body, and irregular heartbeat. Traditional Chinese medicine believes that the disease is related to heart blood loss, qi deficiency and blood stasis, and pathogenic heat disturbing the heart. About 500,000 people die from this disease every year in the United States, accounting for 1/3-1/2 of the number of patients, accounting for 50-70% of the number of deaths from heart disease. The incidence rate in our country is about 30%, accounting for more than 40% of the death toll, and increasing year by year, it has become the main cause of population death.
心肌缺血性疾病的发病随年龄的增长而增高,程度也随年龄的增长而加重。有资料表明,自40岁开始,每增加10岁,心肌缺血性疾病的患病率增1倍。男性50岁,女性60岁以后,冠状动脉硬化发展比较迅速,同样心肌梗塞的危险也随着年龄的增长而增长。The incidence of myocardial ischemic disease increases with age, and the degree also increases with age. According to data, starting from the age of 40, the prevalence of myocardial ischemic diseases doubles for every 10 years of age. After the age of 50 for men and 60 for women, coronary arteriosclerosis develops rapidly, and the risk of myocardial infarction also increases with age.
目前治疗心肌缺血性疾病的药物较多,常用的主要为化学药物,包括硝酸酯制剂、肾上腺素能β受体阻滞剂(β阻滞剂)、钙通道阻滞剂、抗血小板药物、调整血脂药物、抗凝药物。西药治疗常常导致一些不良反应,如诱发支气管哮喘,抑制心脏,引起心力衰竭等。治疗心肌缺血性疾病的中成药品种也不少,比较常用的有丹参制剂、复方银杏制剂、速效救心丸等等,这些药品有一定的治疗作用,但是存在一定的问题,主要是不同患者个体体质不完全相同,所以治疗时药物的疗效也不完全相同,有的甚至没有作用,而且这些药品中有些药物具有一定的耐药性,患者需要终身带药,这样影响患者的生活质量。At present, there are many drugs for the treatment of myocardial ischemic diseases, and the commonly used drugs are mainly chemical drugs, including nitrate preparations, adrenergic β receptor blockers (β blockers), calcium channel blockers, antiplatelet drugs, Adjust blood lipid drugs and anticoagulant drugs. Western medicine treatment often leads to some adverse reactions, such as inducing bronchial asthma, inhibiting the heart, and causing heart failure. There are also many kinds of Chinese patent medicines for the treatment of myocardial ischemic diseases. The more commonly used ones are Danshen preparations, compound ginkgo preparations, Suxiao Jiuxin pills, etc. These medicines have certain therapeutic effects, but there are certain problems, mainly due to different individual patients. The physique is not exactly the same, so the curative effect of the drugs during treatment is also not the same, and some even have no effect, and some of these drugs have certain drug resistance, and patients need to take the drugs for life, which affects the quality of life of patients.
基于上述原因,研究一种安全、有效、快速的药物是行之有效的预防和治疗心肌缺血性疾病的一项重要任务。研制开发具有见效快、疗效确切、毒副作用小等特点的预防和治疗心肌缺血的药物以减少心血管疾病对人类健康的威胁是一项十分有意义的工作。Based on the above reasons, researching a safe, effective and rapid drug is an important task for the effective prevention and treatment of myocardial ischemic diseases. It is a very meaningful work to research and develop drugs for the prevention and treatment of myocardial ischemia with the characteristics of quick effect, definite curative effect, and small toxic and side effects, so as to reduce the threat of cardiovascular diseases to human health.
发明内容 Contents of the invention
本发明所要解决的技术问题在于克服目前在治疗心肌缺血性疾病上的不足之处,并提供一种取材容易、制备方便、费用低廉且治愈率较高的治疗心肌缺血的中药制剂。The technical problem to be solved by the present invention is to overcome the shortcomings in the current treatment of myocardial ischemia and provide a traditional Chinese medicine preparation for the treatment of myocardial ischemia which is easy to obtain materials, convenient to prepare, low in cost and high in cure rate.
为解决上述技术问题,本发明提供了一种治疗心肌缺血的中药制剂,各种成分的重量份数比为:杜仲10~20份、羌活10~20份、葛根10~20份、丹参10~20份、当归10~20份、天麻10~20份、黄芪10~20份、虎杖10~20份、积雪草10~20份、川芎10~20份、茯苓10~20份、肉桂10~20份、白术10~20份、连翘10~20份、熟地10~20份、何首乌10~20份、阿胶10~20份、甘草10~20份。In order to solve the above-mentioned technical problems, the present invention provides a traditional Chinese medicine preparation for treating myocardial ischemia. The weight-to-number ratios of various components are: Eucommia 10-20 parts, notopterygium 10-20 parts, kudzu root 10-20 parts, salvia miltiorrhiza 10 parts ~20 parts, Angelica 10~20 parts, Gastrodia elata 10~20 parts, Astragalus 10~20 parts, Polygonum cuspidatum 10~20 parts, Centella asiatica 10~20 parts, Chuanxiong 10~20 parts, Poria cocos 10~20 parts, cinnamon 10 parts ~20 parts, Atractylodes macrocephala 10~20 parts, Forsythia 10~20 parts, Rehmannia glutinosa 10~20 parts, Polygonum multiflorum 10~20 parts, Ejiao 10~20 parts, Licorice 10~20 parts.
所述治疗心肌缺血的中药制剂,各种成分的重量份数比还可以为:杜仲10~15份、羌活10~15份、葛根10~15份、丹参10~15份、当归10~15份、天麻10~15份、黄芪10~15份、虎杖10~15份、积雪草10~15份、川芎15~20份、茯苓15~20份、肉桂15~20份、白术15~20份、连翘15~20份、熟地15~20份、何首乌15~20份、阿胶15~20份、甘草15~20份。For the traditional Chinese medicine preparation for treating myocardial ischemia, the weight-to-number ratio of various components can also be: 10-15 parts of Eucommia, 10-15 parts of Notopterygium, 10-15 parts of Pueraria Radix, 10-15 parts of Salvia Miltiorrhiza, 10-15 parts of Angelica Sinensis 10-15 parts of Tianma, 10-15 parts of Astragalus, 10-15 parts of Polygonum cuspidatum, 10-15 parts of Centella asiatica, 15-20 parts of Chuanxiong, 15-20 parts of Poria cocos, 15-20 parts of cinnamon, 15-20 parts of Atractylodes macrocephala 15-20 parts of forsythia, 15-20 parts of Rehmannia glutinosa, 15-20 parts of fleece-flower root, 15-20 parts of donkey-hide gelatin, and 15-20 parts of licorice.
所述治疗心肌缺血的中药制剂,各种成分的重量份数比又可以为:杜仲15~20份、羌活15~20份、葛根15~20份、丹参15~20份、当归15~20份、天麻15~20份、黄芪15~20份、虎杖15~20份、积雪草15~20份、川芎10~15份、茯苓10~15份、肉桂10~15份、白术10~15份、连翘10~15份、熟地10~15份、何首乌10~15份、阿胶10~15份、甘草10~15份。The traditional Chinese medicine preparation for treating myocardial ischemia, the weight-to-number ratio of various components can be: Eucommia 15-20 parts, Notopterygium 15-20 parts, Pueraria 15-20 parts, Salvia miltiorrhiza 15-20 parts, Angelica sinensis 15-20 parts 15-20 parts of Tianma, 15-20 parts of Astragalus, 15-20 parts of Polygonum cuspidatum, 15-20 parts of Centella asiatica, 10-15 parts of Chuanxiong, 10-15 parts of Poria cocos, 10-15 parts of cinnamon, 10-15 parts of Atractylodes macrocephala 10-15 parts of forsythia, 10-15 parts of Rehmannia glutinosa, 10-15 parts of fleece-flower root, 10-15 parts of donkey-hide gelatin, and 10-15 parts of licorice.
所述治疗心肌缺血的中药制剂,各种成分的重量份数比也可以为:杜仲10~15份、羌活10~15份、葛根10~15份、丹参10~15份、当归15~20份、天麻15~20份、黄芪15~20份、虎杖15~20份、积雪草15~20份、川芎15~20份、茯苓10~20份、肉桂10~20份、白术10~20份、连翘10~20份、熟地10~15份、何首乌10~15份、阿胶10~15份、甘草10~15份。In the traditional Chinese medicine preparation for treating myocardial ischemia, the weight-to-number ratio of various components may also be: 10-15 parts of Eucommia, 10-15 parts of Notopterygium, 10-15 parts of Pueraria Radix, 10-15 parts of Salvia Miltiorrhiza, 15-20 parts of Angelica Sinensis 15-20 parts of Tianma, 15-20 parts of Astragalus, 15-20 parts of Polygonum cuspidatum, 15-20 parts of Centella asiatica, 15-20 parts of Chuanxiong, 10-20 parts of Poria cocos, 10-20 parts of cinnamon, 10-20 parts of Atractylodes macrocephala 10-20 parts of forsythia, 10-15 parts of Rehmannia glutinosa, 10-15 parts of fleece-flower root, 10-15 parts of donkey-hide gelatin, and 10-15 parts of licorice.
所述中药制剂的给药方式可以为口服。The administration method of the traditional Chinese medicine preparation can be oral.
所述中药制剂剂型可以为汤剂、散剂、蜜炼丸剂、水合丸剂,片剂、胶囊、口服液、颗粒剂或糖浆剂。The dosage form of the traditional Chinese medicine preparation can be decoction, powder, honey-distilled pill, hydrated pill, tablet, capsule, oral liquid, granule or syrup.
所述中药制剂的散剂的制备可以包括以下步骤:The preparation of the powder of described Chinese medicine preparation can comprise the following steps:
将所述原料用水刷、洗干净,捞出晾干;Brush and wash the raw materials with water, remove and dry;
将当归、川芎、茯苓、肉桂、熟地分别放入砂锅小火炒5~10分钟,用粉碎机分别将其粉碎成细末,过筛;Put angelica, chuanxiong, poria, cinnamon, and rehmannia glutinosa into casserole and stir-fry for 5-10 minutes on low heat, grind them into fine powder with a grinder, and sieve;
将晾干后的杜仲、羌活、葛根、丹参、天麻、连翘、何首乌、阿胶分别送入切片机中切成小薄片,再将上述处理过的原料以及其余原料送入粉碎机粉碎成细末,过筛。Send the dried eucommia, notopterygium, kudzu root, salvia, gastrodia elata, forsythia, fleece-flower root, and donkey-hide gelatin into a slicer and cut into small slices, and then send the above-mentioned processed raw materials and other raw materials into a pulverizer to grind them into fine powder , sieved.
所述治疗心肌缺血的中药制剂,过筛所用的筛子可以为90~100目。The sieve used for sieving the traditional Chinese medicine preparation for treating myocardial ischemia may be 90-100 mesh.
所述治疗心肌缺血的中药制剂,在粉碎机中粉碎的时间可以为10~20分钟。The traditional Chinese medicine preparation for treating myocardial ischemia can be pulverized in a pulverizer for 10-20 minutes.
所述中药制剂的散剂的制备进一步包括对混合后的细末采用紫外线照射进行消毒的步骤。The preparation of the powder of the traditional Chinese medicine preparation further includes the step of sterilizing the mixed fine powder by ultraviolet irradiation.
与现有技术相比,本发明的优点是:本发明配伍合理疗效显著,见效快,临床实验证明有效率高;本发明治疗心肌缺血的中药制剂使用安全,无毒性,经急毒实验验证,无毒副作用,适用于不同体质的患者,可长期服用;本发明治疗心肌缺血的中药制剂无耐药性,为中药制剂且选材细致,无有依赖性的药物成分,因此病人长期服用也不会产生依赖性。Compared with the prior art, the advantages of the present invention are: reasonable compatibility of the present invention, significant curative effect, quick effect, and high effective rate as proved by clinical experiments; the traditional Chinese medicine preparation for treating myocardial ischemia of the present invention is safe to use, non-toxic, and has been verified by acute toxicity experiments , no toxic side effects, suitable for patients with different constitutions, and can be taken for a long time; the traditional Chinese medicine preparation for the treatment of myocardial ischemia of the present invention has no drug resistance, is a traditional Chinese medicine preparation and has carefully selected materials, and has no dependent drug ingredients, so long-term use is also possible for patients. No dependencies will be created.
具体实施方式 Detailed ways
祖国医学认为:胸痹心痛可因七情内伤,饮食劳倦,外邪所容,正气虚衰等因而发。心主血脉,血脉不通,则心痛卒然而发;七情所伤,则气滞血瘀,心之络脉不通而发;外邪客于心之血脉,脉络绌急不通,卒然而痛;正虚无力帅血而行,血行瘀滞,亦可导致心痛。气机不利,则胸部窒塞憋闷,呼吸不利;心主神,心脉不畅,心神不安,故见心悸怔忡。尽管引发胸痹的原因不同,但瘀血内停,气郁不行,脉络失和,是胸痹心痛的共同病理环节。正如《素问·脉要精微论》曰:“脉者,血之府也,涩则心痛”。因而,活血行气,通脉止痛法,被广泛用于胸痹的治疗。Traditional Chinese medicine believes that chest pain and heartache can be caused by internal injuries of the seven emotions, fatigue from diet, tolerance of exogenous pathogens, deficiency of righteousness, etc. The heart governs the blood vessels, and if the blood vessels are blocked, heartache and death will occur; if the seven emotions are injured, qi stagnation and blood stasis will occur, and the heart collaterals will be blocked; Deficiency causes blood to flow, and blood stasis can also cause heartache. If the Qi movement is unfavorable, the chest will be suffocated and oppressed, and the breathing will be difficult; the heart governs the mind, the heart arteries will not flow smoothly, and the mind will be restless, so palpitations and palpitations will be seen. Although the causes of thoracic obstruction are different, internal stagnation of blood stasis, stagnation of qi, and disharmony of veins are the common pathological links of thoracic obstruction and heartache. Just as "Su Wen·The Essence of the Pulse" says: "The pulse is the home of blood, and astringent causes heartache." Therefore, the method of activating blood and promoting qi, dredging channels and relieving pain is widely used in the treatment of chest obstruction.
本发明治疗心肌缺血的中药制剂,各味药物的作用在于:The present invention treats the Chinese medicine preparation of myocardial ischemia, and the effect of each taste medicine is:
杜仲:治腰脊酸疼,肢体痿弱,遗精,滑精,五更泄泻,虚劳,小便余沥,阴下湿痒。王好古:“肝经气分。”《雷公炮制药性解》:“入肾经。”《本草经解》:“入手太阴肺经。”牛膝补肝肾,强筋骨,逐瘀通经,引血下行。用于腰膝酸痛,筋骨无力,经闭症瘕,肝阳眩晕。Eucommia ulmoides: Treat waist and spine pain, flaccidity and weakness of limbs, nocturnal emission, slippery essence, diarrhea at dawn, asthenia, urination, dampness and itching in the genitals. Wang Haogu: "Liver Meridian Qi Division." "Lei Gong Pao Pharmacy Solution": "Enter the Kidney Channel." "Materia Medica Classic Explanation": "Start with the Taiyin Lung Channel." , to draw blood down. For soreness of the waist and knees, weakness of muscles and bones, amenorrhea in the abdomen, dizziness due to liver yang.
羌活:散寒解表,祛风湿,止痛。辛温,气雄而散,发表力强,主散太阳经风邪及寒湿之邪,有散寒祛风、胜湿止痛之功,故善治风寒湿邪龙表,恶寒发热、肌表无汗、头痛项强、肢体酸痛者。Notopterygium: expelling cold, relieving exterior syndrome, expelling rheumatism, relieving pain. Pungent and warm, qi is strong and dissipating, with strong expressive power. It mainly dispels the pathogenic wind and cold-damp in the sun meridian. It has the functions of dispelling cold and expelling wind, overcoming dampness and relieving pain. Those with no sweat, headache, strong neck, and sore limbs.
葛根:解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。现代医学研究表明:葛根中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。Radix Puerariae: relieves exterior syndrome and reduces fever, promotes fluid production, relieves rash, promotes yang and relieves diarrhea. For exogenous fever and headache, high blood pressure and neck pain, thirst, thirst, impervious measles, dysentery, and diarrhea. "Compendium of Materia Medica" contains: Radix Puerariae, cool in nature, flat in breath, sweet in taste, has the functions of clearing heat, reducing fire, and detoxifying. Modern medical research shows that puerarin, an isoflavone compound in kudzu root, has certain curative effects on hypertension, hyperlipidemia, hyperglycemia and cardiovascular and cerebrovascular diseases.
丹参:丹参能够促进组织的修复与再生,丹参能够促进纤维母细胞分化、胶原纤维形成较明显;肉芽形成比较成熟。局部淤血减轻、血液循环改善,愈合时间缩短。抑制过度增生对过度增生的纤维母细胞有抑制作用。Salvia miltiorrhiza: Salvia miltiorrhiza can promote the repair and regeneration of tissues. Salvia miltiorrhiza can promote the differentiation of fibroblasts, and the formation of collagen fibers is more obvious; the formation of granulation is more mature. Local congestion is reduced, blood circulation is improved, and healing time is shortened. Inhibition of hyperproliferation has an inhibitory effect on hyperproliferative fibroblasts.
当归:补血活血,调经止痛,润肠通便。莪术破血行气止痛,温通力较大,可治疗血滞经闭腹痛、腹部包块、积聚,消积散结,行气消积止痛,破血祛瘀,行气止痛。Angelica: Enriches and activates blood circulation, regulates menstruation and relieves pain, laxes bowels. Curcuma breaks blood, promotes qi and relieves pain, and has a large warming force. It can treat abdominal pain, abdominal mass and accumulation due to stagnation of blood, eliminate stagnation and dissipate stagnation, promote qi, eliminate stagnation and relieve pain, break blood and remove blood stasis, promote qi and relieve pain.
天麻:平肝息风止痉。用于头痛眩晕,肢体麻木,手足不遂,小儿惊风,癫痫抽搐,破伤风。Gastrodia elata: calming the liver, calming the wind and relieving convulsions. For headache and dizziness, limb numbness, limb paralysis, convulsions in children, epileptic convulsions, and tetanus.
黄芪补气升阳,托疮生肌;用于温养脾胃而生肌,用于气血不足,疮疡内陷,久溃不敛;健脾益气,且有调节机体的免疫功能。Astragalus nourishes qi and promotes yang, stimulates sores and promotes granulation; it is used to warm and nourish the spleen and stomach to promote granulation, and it is used for insufficient qi and blood, sores and sores that are sunken for a long time; it strengthens the spleen and qi, and can regulate the immune function of the body.
虎杖、微苦,微寒。归肝、胆、肺经。祛风利湿,散瘀定痛,止咳化痰。用于关节痹痛,湿热黄疸,经闭,症瘕,水火烫伤,跌扑损伤,痈肿疮毒,咳嗽痰多。《本草述》:虎杖之主治,其行血似与天名精类,其疗风似与王不留行类,第前哲多谓其最解暑毒,是则从血所生化之原以除结热,故手厥阴之血脏与足厥阴之风脏,其治如鼓应桴也。方书用以疗痉病者,同于诸清热之味,以其功用为切耳,然于他证用之亦鲜,何哉?方书用以治淋,即丹溪疗老人气血受伤之淋,亦以为要药,于补剂中用之矣。谓虚人服之有损者,与补剂并行,其庶几乎。Polygonum cuspidatum, slightly bitter, slightly cold. Return liver, gallbladder, lung meridian. Expelling wind and dampness, dissipating blood stasis and relieving pain, relieving cough and reducing phlegm. Used for arthralgia, damp-heat jaundice, amenorrhea, lump in the abdomen, water and fire burns, injuries from falls, carbuncles and sores, cough with excessive phlegm. "Compendium of Materia Medica": Indications of Polygonum cuspidatum, its circulation of blood seems to be similar to that of Tianming Jing, and its treatment of wind is similar to that of Wang Buliu Xing. The first Zhe said that it is the most detoxifying summer heat, and it is from the origin of blood biochemical to eliminate Condensation of heat, so the blood viscera of the Jueyin of the hand and the wind viscera of the Jueyin of the foot are cured like a drum. Prescriptions are used to treat convulsions, the same as all the heat-clearing flavors, and their functions are regarded as ear-piercing, but it is not used in other syndromes, why? The prescription is used to treat stranguria, that is, Danxi treats stranguria with injured Qi and blood of the elderly, and it is also regarded as an important medicine, which is used in tonics. Those who are said to be harmful to people who take it, go hand in hand with supplements, and the effect is almost the same.
积雪草苦、辛,寒。归肝、脾、肾经。清热利湿,解毒消肿。用于湿热黄疸,中暑腹泻,砂淋血淋,痈肿疮毒,跌扑损伤。Centella asiatica is bitter, pungent, and cold. Return liver, spleen, kidney channel. Clearing heat and promoting dampness, detoxification and detumescence. For damp-heat jaundice, heatstroke diarrhea, sandy drench with blood, carbuncle sores, and injuries from falls.
川芎辛,温。归肝、胆、心包经。活血行气,祛风止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《别录》:"除脑中冷动,面上游风去来,目泪出,多涕唾,忽忽如醉,诸寒冷气,心腹坚痛,中恶,卒急肿痛,胁风痛,温中内寒。"《药性论》:"治腰脚软弱,半身不遂,主胞衣不出,治腹内冷痛。"《日华子本草》:"治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破症结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血。"Rhizoma Chuanxiong is pungent, warm. Return liver, gallbladder, pericardium channel. Promoting blood circulation and promoting qi, expelling wind and relieving pain. Control wind-cold headache, dizziness, hypochondriac pain, abdominal pain, arthralgia due to cold, cramps, amenorrhea, dystocia, postpartum stasis block pain, carbuncle sore. For irregular menstruation, amenorrhea dysmenorrhea, abdominal pain in the abdomen, tingling pain in the chest and hypochondrium, tumbling and swelling pain, headache, rheumatic arthralgia. "Bie Lu": "In addition to the cold movement in the brain, the wind coming and going on the face, tears coming out of the eyes, excessive tears and saliva, sudden drunkenness, all kinds of cold air, hard pain in the heart and abdomen, evil in the heart, acute swelling and pain in the chest, wind pain in the flank, Warming the middle and internal cold." "Medicine Properties": "Treating weakness of the waist and feet, hemiplegia, prolapse of the main body clothes, and cold pain in the abdomen." "Nihuazi Materia Medica": "Cure all wind, all qi, all strain Blood, tonifies five fatigues, strengthens muscles and bones, adjusts multiple channels, breaks out stagnant blood, nourishes new blood, grows flesh, nasal flood, vomiting and drowning, hemorrhoids, fistula, back pain, scrofula, galls, sores and scabies, and Drain pus and eliminate blood stasis."
茯苓性甘、平、淡,具有利水渗湿、健脾、安神的功能。并能促进人体的免疫功能;乙醚或乙醇提取物能使离体蛙心收缩加强,对家兔血糖则先使升高而后降低。茯苓煎剂对小鼠有镇静作用。Poria cocos is sweet, flat, and light in nature, and has the functions of diuretic and dampness, invigorating the spleen, and calming the nerves. And it can promote the immune function of the human body; ether or ethanol extract can strengthen the contraction of the isolated frog heart, and increase the blood sugar of rabbits first and then reduce it. Poria decoction has a sedative effect on mice.
肉桂性大热,味辛、甘。补火助阳,引火归源,散寒止痛,活血通经。用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。《本草拾遗》:箘桂、牡桂、桂心,已上三色,并同是一物。按桂林、桂岭,因桂为名,今之所生,不离此郡。从岭以南际海,尽有桂树,惟柳、象州最多。味即辛烈,皮又厚坚,厚者必嫩,薄者必老。以老薄者为一色,以厚嫩者为一色,嫩即辛香,兼又筒卷;老必味淡,自然板薄。板薄者,即牡桂也,以老大而名焉;筒卷者,即箘桂也,以嫩而易卷。古方有筒桂,字似箘字,后人误而书之,习而成俗,至于书传,亦复因循。桂心即是削除皮上甲错,取其近里,辛而有味。Cinnamon is very hot, spicy and sweet. Supplementing fire and supporting yang, drawing fire back to its source, dispelling cold and relieving pain, promoting blood circulation and stimulating menstruation. For impotence, uterine cold, confidant cold pain, deficiency-cold vomiting and diarrhea, amenorrhea, dysmenorrhea, warming meridians and dredging channels. "Supplements to Materia Medica": Guigui, Mugui, and Guixin have three colors and are the same thing. According to Guilin and Guiling, it is named after Guilin, and it is born today and does not leave this county. From the south of the ridge to the sea, there are all osmanthus trees, but willows and Xiangzhou are the most numerous. The taste is pungent, and the skin is thick and firm. If it is thick, it will be tender, and if it is thin, it will be old. The old and thin ones are the same color, and the thick and tender ones are the same color. Tenderness is spicy, and it is also rolled; old must be light, and naturally thin. The thin ones are Mu Gui Ye, which is named after the big ones; the rolled ones are the Kui Gui Ye, which are tender and easy to roll. In ancient times, there was Tonggui, whose characters resembled the characters of 箘. Later generations wrote it by mistake, and it became a custom after habit. As for the transmission of books, they followed suit. Guixin is to peel off the nails on the skin, and take the inner part, which is pungent and flavorful.
白术性苦、甘、咸、寒,具有清热、解毒、养阴之功能。白术具有健脾益气,燥湿利水,止汗,安胎的功效。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《医学启源》记载:“除湿益燥,和中益气,温中,去脾胃中湿,除胃热,强脾胃,进饮食,止渴,安胎。”Atractylodes macrocephala is bitter, sweet, salty, and cold in nature, and has the functions of clearing heat, detoxifying, and nourishing yin. Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizome has the effect of invigorating the spleen and replenishing qi, drying dampness and promoting diuresis, antiperspirant and preventing miscarriage. For insufficiency of the spleen, lack of food, abdominal distension and diarrhea, dizziness and palpitation due to phlegm and retention, edema, spontaneous sweating, restless fetal movement. "Medical Genesis" records: "Remove dampness and benefit dryness, harmonize the middle and replenish qi, warm the middle, remove dampness in the spleen and stomach, remove stomach heat, strengthen the spleen and stomach, eat food, quench thirst, and prevent pregnancy."
连翘苦,微寒。归肺、心、小肠经。清热解毒,消肿散结。用于痈疽,瘰疬,乳痈,丹毒,风热感冒,温病初起,温热入营,高热烦渴,神昏发斑,热淋尿闭。连翘药用部分主要是果实。它的果壳,即“羚翘解毒丸”中的“翘”。含有连翘酚、香豆精、齐墩果酸、皂甙、维生素P等。具有清热、解毒、散结排脓等功效。主治温热、疮疡、瘰疬、丹毒、班疹、流感。Forsythia bitter, slightly cold. Return lung, heart, small intestine channel. Heat-clearing and toxic substances removing, reducing swelling and dissipating stagnation. For carbuncle, scrofula, breast carbuncle, erysipelas, wind-heat cold, febrile disease at the onset, warm-heat enters the camp, high fever and polydipsia, coma and spots, heat-drenched urine retention. The medicinal part of forsythia is mainly the fruit. Its husk is the "Qiao" in "Lingqiao Jiedu Pills". Contains forsythol, coumarin, oleanolic acid, saponins, vitamin P, etc. It has the effects of clearing away heat, detoxifying, dispelling stagnation and draining pus. Indications for fever, sores, scrofula, erysipelas, rash, influenza.
熟地味甘,性微温。归肝、肾经。具有补血滋阴功效。用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症。可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等;补精益髓功效用于肝肾精血亏虚的腰膝酸软,眩晕耳鸣,须发早白等。Rehmannia glutinosa is sweet in taste and slightly warm in nature. Return liver, kidney channel. It has the effect of nourishing blood and nourishing yin. For blood deficiency and chlorosis, dizziness, palpitation, insomnia, irregular menstruation, metrorrhagia embolism. It can be used for hot flashes, night sweats, nocturnal emission, diabetes, etc. due to deficiency of kidney yin; it can be used for soreness of waist and knees, dizziness, tinnitus, premature graying of beard and hair, etc. due to deficiency of liver and kidney essence and blood.
何首乌苦、甘、涩,温。归肝、心、肾经。解毒,消痈,润肠通便。用于瘰疠疮痈,风疹瘙痒,肠燥便秘;高血脂。现代医学研究表明,何首乌具有增强免疫的功能。何首乌对强的松龙和环磷酰胺引起的老年小鼠脾、胸腺抑制性改变有明显对抗作用,使脾巨噬细胞的吞噬率和吞噬指数明显提高。饲喂首乌乙醇浸膏能明显提高老年大鼠外周淋巴细胞DNA的损伤修复能力。小鼠灌服制首乌6g/kg,连续给药7日,能明显提高腹腔巨噬细胞的吞噬能力,对强的松龙引起的吞噬指数下降,有明显的对抗作用。何首乌水煎醇提物对小鼠T淋巴细胞及B淋巴细胞免疫功能均有增强作用,前者作用更为显著。何首乌提取物25-100mg/kg,腹腔注射,连续给药3日,可显著提高正常小鼠由ConA诱导的胸腺和脾脏T淋巴细胞增殖反应;皮下注射5-100g/kg,连续3日,可明显增加正常小鼠脾脏抗体形成细胞数,以50g/kg组作用最显著。Polygonum multiflorum is bitter, sweet, astringent, warm. Return liver, heart, kidney channel. Detoxifcation, disappear carbuncle, laxative. For scrofula carbuncle, rubella pruritus, intestinal dryness and constipation; hyperlipidemia. Modern medical research shows that Polygonum multiflorum has the function of enhancing immunity. Polygonum multiflorum has obvious antagonism to the inhibitory changes in the spleen and thymus of aged mice induced by prednisolone and cyclophosphamide, and significantly increases the phagocytic rate and phagocytic index of spleen macrophages. Feeding Shouwu ethanol extract can significantly improve the DNA damage repair ability of peripheral lymphocytes in aged rats. Mice fed Shouwu 6g/kg for 7 consecutive days, which can significantly improve the phagocytic ability of peritoneal macrophages, and has obvious antagonism to the decrease of phagocytic index caused by prednisolone. The alcohol extract of Polygonum multiflorum decocted in water can enhance the immune function of T lymphocytes and B lymphocytes in mice, and the effect of the former is more significant. Polygonum multiflorum extract 25-100mg/kg, intraperitoneal injection, continuous administration for 3 days, can significantly improve the proliferation of thymus and spleen T lymphocytes induced by ConA in normal mice; subcutaneous injection of 5-100g/kg, continuous 3 days, can Significantly increase the number of antibody-forming cells in the spleen of normal mice, and the effect is most significant in the 50g/kg group.
阿胶甘,平。《本经》:"味甘,平。"《别录》:"微温,无毒。"《医学启源》:"《主治秘诀》云,性平,味淡。"入肺、肝、肾经。滋阴补血,安胎。治血虚,虚劳咳嗽,吐血,衄血、便血,妇女月经不调,崩中,胎漏。《本经》:"主心腹内崩,劳极洒洒如疟状,腰腹痛,四肢酸疼,女子下血。安胎。久服益气。"《别录》:"丈夫小腹痛,虚劳羸瘦,阴气不足,脚酸不能久立,养肝气。"《药性论》:"主坚筋骨,益气止痢。"《千金·食治》:"治大风。"Donkey-hide gelatin sweet, flat. "Ben Jing": "Taste sweet, flat." "Bie Lu": "Temperature, non-toxic." through. Nourish yin and enrich blood, prevent miscarriage. Control blood deficiency, consumptive cough, vomiting blood, epistaxis, blood in stool, irregular menstruation in women, metrorrhagia, fetal leakage. "The Classic": "The main confidant is collapsed, the fatigue is like a malaria, the waist and abdomen pain, the limbs are sore, and the woman is bleeding. Anti-fertility. Long-term use to replenish Qi." "Bie Lu": "The husband has lower abdomen pain, fatigue Lean and thin, lack of yin qi, sore feet can not stand for a long time, nourish liver qi." "On the Properties of Medicine": "Maintains strengthening muscles and bones, nourishing qi and stopping dysentery." "Qian Jin · Food Treatment": "Treating strong wind."
甘草甘,平。归心、肺、脾、胃经。补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。甘草性味甘,平。人心、肺、脾、胃经。入药能泻火解毒、润肺祛痰止咳,益气补中、缓急止痛、缓和药性,用于治疗心气不足、心悸怔忡、脉结代、脾胃虚弱、气血不足、倦怠无力,以及腹中痉挛急疼痛等症。甘草的药性缓和,可升、可降,可以与补药、泻药、寒药、温药、凉药等各类药物配合使用,并有调和药性的作用。西医药理发现,甘草剂有抗炎和抗变态反映的功能,因此在西医临床上主要作为缓和剂。缓解咳嗽,祛痰,治疗咽痛喉炎;甘草或甘草次酸有去氧皮质酮类作用,对慢性肾上腺皮质功能减退症有良好功效;甘草制剂能促进胃部粘液形成和分泌,延长上皮细胞寿命,有抗炎活性,常用于慢性溃疡和十二指肠溃疡的治疗;甘草的黄酮具有消炎、解痉和抗酸作用。Licorice Gan, flat. GUIXIN, lung, spleen, stomach warp. Invigorating the spleen and replenishing qi, clearing away heat and detoxification, eliminating phlegm and relieving cough, relieving spasm and relieving pain, harmonizing various medicines. For weakness of the spleen and stomach, lassitude and weakness, palpitation and shortness of breath, cough with copious phlegm, epigastric abdomen, extremity convulsion acute pain, carbuncle sore tumefacting virus, alleviates drug toxicity, strong. Licorice is sweet in nature and flavor, flat. Heart, lung, spleen, stomach meridian. Used as a medicine, it can purify fire and detoxify, moisten the lungs, eliminate phlegm and relieve cough, replenish qi and invigorate the middle, relieve spasms and relieve pain, and alleviate the properties of the medicine. acute pain embolism. The medicinal properties of licorice are moderate and can be increased or decreased. It can be used in conjunction with various medicines such as tonics, laxatives, cold medicines, warm medicines, and cold medicines, and has the effect of reconciling the medicinal properties. Western medicine has found that licorice has anti-inflammatory and anti-allergic functions, so it is mainly used as a palliative in Western medicine. Relieve cough, eliminate phlegm, and treat sore throat and laryngitis; licorice or glycyrrhetinic acid has the effect of deoxycorticosterone, which has a good effect on chronic adrenal insufficiency; Lifespan, has anti-inflammatory activity, and is often used in the treatment of chronic ulcers and duodenal ulcers; the flavonoids of licorice have anti-inflammatory, antispasmodic and antacid effects.
心肌缺血性疾病多发于40岁以上的中老年人,人过中年,正气渐衰,且活血行气诸药,性多开破,易伤正气,故佐以益气养阴扶正之品,既可扶正以祛邪,又可祛邪而不伤正,相是益彰。气滞血瘀之胸痹,乃瘀血气滞交相为患。气帅血行,气滞则血瘀;瘀血阻遏,气机不畅。瘀血气滞痹阻心脉,气血不通,故卒然而痛。针对上述病机,本方主要功能是行气活血。行气与活血并重,配伍严谨,祛邪与扶正并施,共奏理气化瘀、补益气血、调理脾胃之功。Myocardial ischemic diseases mostly occur in middle-aged and elderly people over the age of 40. After middle age, the righteousness gradually declines, and the medicines for promoting blood circulation and promoting Qi tend to break down in nature, so it is easy to damage the righteousness. , it can not only strengthen the body to get rid of the evil, but also get rid of the evil without hurting the body, which complement each other. Qi stagnation and blood stasis of chest obstruction, is the intersection of blood stagnation and Qi stagnation. Qi is handsome and blood moves, and stagnation of qi leads to blood stasis; when blood stasis is blocked, the movement of qi is not smooth. Blood stasis and qi stagnation block the heart vessels, and qi and blood are blocked, so death is painful. Aiming at the above pathogenesis, the main function of this prescription is to promote qi and blood circulation. Equal emphasis is placed on promoting qi and promoting blood circulation, and the compatibility is strict. Expelling evil and strengthening the body are applied together, and they play the role of regulating qi and removing blood stasis, replenishing qi and blood, and regulating the spleen and stomach.
本发明治疗心肌缺血的中药制剂按照下述方法制备散剂剂型的药物:The Chinese medicinal preparation for the treatment of myocardial ischemia of the present invention prepares the medicine of powder formulation according to the following method:
将所述原料用水刷、洗干净,捞出晾干;Brush and wash the raw materials with water, remove and dry;
将当归、川芎、茯苓、肉桂、熟地分别放入砂锅小火炒5~10分钟,用粉碎机分别将其粉碎10分钟,待其成细末,100目筛子过筛;Put angelica, chuanxiong, poria, cinnamon, and rehmannia glutinosa into casserole and stir-fry on low heat for 5-10 minutes, grind them with a grinder for 10 minutes, wait until they are fine, and sieve through a 100-mesh sieve;
将晾干后的杜仲、羌活、葛根、丹参、天麻、连翘、何首乌、阿胶分别送入切片机中切成小薄片,再将上述处理过的原料以及其余原料送入粉碎机粉碎20分钟,待其成细末,90目过筛,过筛后的细末采用紫外线照射进行消毒,分包待用。Send the dried eucommia, notopterygium, kudzu root, salvia, gastrodia elata, forsythia, fleece-flower root, and donkey-hide gelatin into a slicer and cut into small slices, and then send the above-mentioned treated raw materials and other raw materials into a pulverizer for crushing for 20 minutes. After it becomes fine powder, it is sieved with 90 meshes, and the fine powder after sieving is sterilized by ultraviolet irradiation, and then subpackaged for use.
药效学实验:Pharmacodynamics experiment:
该药对小鼠耐缺氧能力的保护作用:试验小鼠120只,雄性,动物末次给药后每组随机再分为常压、常压+ISO和低压三种条件下进行试验,结果用表明该药治疗8天,具有明显增强小鼠耐缺氧能力。The protective effect of the drug on the ability of mice to withstand hypoxia: 120 test mice, male, each group was randomly divided into normal pressure, normal pressure+ISO and low pressure for testing under three conditions after the last administration of the animals. Show that this medicine treats 8 days, can obviously enhance the hypoxia tolerance ability of mice.
对垂体后叶素所致大鼠心肌缺血的影响:动物实验表明,对缺血前后的血压、心率及心电图阳性检出率的实验表明该药能明显对抗垂体后叶素引起的心肌缺血症状。对于有垂体后叶素引起的血清乳酸脱氢同工酶的改变表明对心肌有明显的保护作用。Effect on myocardial ischemia induced by pituitrin: animal experiments showed that the blood pressure, heart rate and electrocardiogram positive detection rate before and after ischemia showed that the drug can significantly resist myocardial ischemia caused by pituitrin symptom. The change of serum lactate dehydrogenase isoenzyme caused by vasopressin showed obvious protective effect on the myocardium.
对大鼠血清总胆固醇和血小板聚集和粘附功能的影响:动物实验表明能显著降低血清和肝脏胆固醇含量,能显著改善血小板的聚集和粘附功能。Effects on rat serum total cholesterol and platelet aggregation and adhesion function: Animal experiments have shown that it can significantly reduce serum and liver cholesterol levels, and can significantly improve platelet aggregation and adhesion functions.
对小鼠应激能力的影响:64只大鼠随机分组治疗6天后,除正常组外,其余各组造成血瘀动物模型,次日给药治疗后测全血比粘度,血浆比粘度,红细胞压积百分率,红细胞聚积指数等指标。结果表明该药对血瘀大鼠高切变率,低切变率,RBC聚积指数和血浆比粘度与对照比较有明显改善作用。Effects on the stress ability of mice: 64 rats were randomly divided into groups and treated for 6 days. Except for the normal group, the other groups were established as animal models of blood stasis. The specific viscosity of whole blood, plasma specific viscosity, red blood cell Packing percentage, red blood cell aggregation index and other indicators. The results showed that the drug had a significant improvement effect on the high shear rate, low shear rate, RBC accumulation index and plasma specific viscosity of rats with blood stasis compared with the control.
对大鼠心脏功能及血流动力学的影响:可明显增加正常大鼠的CO、CI,小剂量该药尚可升高LVSP,以35分钟显著。对其他心脏功能及血流动力学指标无明显影响。Effects on cardiac function and hemodynamics in rats: It can significantly increase CO and CI of normal rats, and a small dose of the drug can still increase LVSP, which is significant within 35 minutes. It has no significant effect on other cardiac function and hemodynamic indicators.
对缺血心肌功能、代谢和形态的影响:Effects on ischemic myocardium function, metabolism and morphology:
1、该药对缺血大鼠心脏功能及血流动力学的影响:实验证明,MI(心肌梗死)组在梗塞后35分钟,50分钟时平均动脉压、Lvsp、-dp/atmax、CO、CI等均显著降低,而该药可使MI后的平均动脉压,LVSP、+dp/dtmax、CO、CI等增大,以小剂量组最显著。1. The effect of the drug on cardiac function and hemodynamics in ischemic rats: Experiments have shown that the mean arterial pressure, Lvsp, -dp/atmax, CO, CI and so on were significantly reduced, but the drug could increase the mean arterial pressure after MI, LVSP, +dp/dtmax, CO, CI and so on, especially in the small dose group.
2、对急性缺血心肌形态变化的影响:从镜检结果可见,各梗塞及梗塞干预组均有灶壮心肌梗死;MI组为9/10例,小剂量组为2/8例,大剂量组为5/11例,阳性对照组为6/11例,说明本发明中药制剂有减轻心肌坏死的作用。2. The influence on the morphological changes of acute ischemic myocardium: From the results of microscopic examination, it can be seen that all infarction and infarction intervention groups had focal myocardial infarction; 9/10 cases in the MI group, 2/8 cases in the low-dose group, and 2/8 cases in the high-dose group The group was 5/11 cases, and the positive control group was 6/11 cases, indicating that the Chinese medicine preparation of the present invention has the effect of alleviating myocardial necrosis.
典型病例1:张女士,48岁,患病5年,胸闷气短,胸痛失眠,头晕心悸,乏力,舌暗苔腻,脉沉细。使用如下配方:Typical case 1: Ms. Zhang, 48 years old, has been ill for 5 years, with chest tightness, shortness of breath, chest pain, insomnia, dizziness, palpitations, fatigue, dark tongue with greasy coating, deep thready pulse. Use the following recipe:
杜仲10g、羌活10g、葛根10g、丹参10g、当归10g、天麻10g、黄芪10g、虎杖10g、积雪草10g、川芎10g、茯苓10g、肉桂10g、白术10g、连翘10g、熟地10g、何首乌10g、阿胶10g、甘草10g。Eucommia 10g, Notopterygium 10g, Pueraria 10g, Salvia 10g, Angelica 10g, Gastrodia elata 10g, Astragalus 10g, Polygonum cuspidatum 10g, Centella asiatica 10g, Chuanxiong 10g, Poria 10g, Cinnamon 10g, Atractylodes macrocephala 10g, Forsythia 10g, Rehmannia glutinosa 10g, Polygonum multiflorum 10g , donkey-hide gelatin 10g, licorice 10g.
经服本发明中药汤剂35剂症状明显减轻,至今未复发。After taking 35 doses of Chinese medicine decoction of the present invention, the symptoms are obviously alleviated, and there is no recurrence so far.
典型病例2:汪女士,53岁,患者自述近几个月来,感觉心口发闷,心跳有时跳得很厉害,左胸刺痛,有时痛引背部,苔暗脉弦细,证属心血瘀阻。使用如下配方:Typical case 2: Ms. Wang, 53 years old, the patient reported that in the past few months, she felt stuffy in her chest, her heart beat sometimes violently, her left chest was stabbed, and sometimes her back was painful, her fur was dark and her pulse was stringy, and the syndrome was heart blood stasis. resistance. Use the following recipe:
杜仲10g、羌活10g、葛根10g、丹参10g、当归10g、天麻10g、黄芪10g、虎杖10g、积雪草10g、川芎15g、茯苓15g、肉桂15g、白术15g、连翘15g、熟地15g、何首乌15g、阿胶15g、甘草15g。Eucommia 10g, Notopterygium 10g, Pueraria 10g, Salvia 10g, Angelica 10g, Gastrodia elata 10g, Astragalus 10g, Polygonum cuspidatum 10g, Centella asiatica 10g, Chuanxiong 15g, Poria 15g, Cinnamon 15g, Atractylodes macrocephala 15g, Forsythia 15g, Rehmannia glutinosa 15g, Polygonum multiflorum 15g , donkey-hide gelatin 15g, licorice 15g.
采用本发明中药内服汤药,先服20剂,症状明显好转,继而又服20剂,心口发闷以及左胸刺痛等症状基本消失。6个月后追访,未见复发。Adopt Chinese medicine decoction for oral administration of the present invention, take 20 doses first, the symptom obviously takes a turn for the better, then take 20 doses again, the symptoms such as heart feeling stuffy and left chest tingling disappear substantially. Follow-up visit after 6 months, no recurrence.
典型病例3,赵先生,63岁,三年前开始患病,症为冠心病,气喘胸闷憋气,陈发性痛疼,有时反射到背部,四肢厥冷,浑身乏力,多次反复发作。使用如下配方:Typical case 3, Mr. Zhao, 63 years old, began to suffer from coronary heart disease three years ago. The symptoms were coronary heart disease, asthma, chest tightness and suffocation, persistent pain, sometimes reflected to the back, cold limbs, fatigue, and repeated attacks. Use the following recipe:
杜仲15g、羌活15g、葛根15g、丹参15g、当归15g、天麻15g、黄芪15g、虎杖15g、积雪草15g、川芎10g、茯苓10g、肉桂10g、白术10g、连翘10g、熟地10g、何首乌10g、阿胶10g、甘草10g。Eucommia 15g, Notopterygium 15g, Pueraria 15g, Salvia 15g, Angelica 15g, Gastrodia elata 15g, Astragalus 15g, Polygonum cuspidatum 15g, Centella asiatica 15g, Chuanxiong 10g, Poria 10g, Cinnamon 10g, Atractylodes macrocephala 10g, Forsythia 10g, Rehmannia glutinosa 10g, Polygonum multiflorum 10g , donkey-hide gelatin 10g, licorice 10g.
经服本发明中药汤剂40剂症状明显减轻,后又服用本发明中药散剂1月,巩固疗效,至今四年未复发。After taking 40 doses of Chinese medicine decoction of the present invention, the symptoms obviously alleviated, and then took the Chinese medicine powder of the present invention for 1 month to consolidate the curative effect, so far no recurrence in four years.
典型病例4:冷男士,61岁,患者冠心病心绞痛病史二年,近一月来发作频繁,每周3~5次,每次持续约5~6分钟,动则胸痛、心悸,胸闷憋气,烦热躁动,自服“复方丹参滴丸”可缓解,痛甚时则需含服“硝酸甘油片”。临床诊断为冠心病心绞痛,属心脉瘀热证。使用如下配方:Typical case 4: Leng male, 61 years old, with a history of angina pectoris of coronary heart disease for two years, frequent attacks in the past month, 3 to 5 times a week, each time lasting about 5 to 6 minutes, chest pain, palpitations, chest tightness and shortness of breath when moving, Dysphoria and restlessness can be relieved by self-administration of "Compound Danshen Dripping Pills". The clinical diagnosis is coronary heart disease angina pectoris, which belongs to the syndrome of blood stasis and heat in the heart vessels. Use the following recipe:
杜仲10g、羌活10g、葛根10g、丹参10g、当归15g、天麻15g、黄芪15g、虎杖15g、积雪草15g、川芎15g、茯苓10g、肉桂10g、白术10g、连翘10g、熟地10g、何首乌10g、阿胶10g、甘草10g。Eucommia 10g, Notopterygium 10g, Pueraria 10g, Salvia 10g, Angelica 15g, Gastrodia elata 15g, Astragalus 15g, Polygonum cuspidatum 15g, Centella asiatica 15g, Chuanxiong 15g, Poria cocos 10g, Cinnamon 10g, Atractylodes macrocephala 10g, Forsythia 10g, Rehmannia glutinosa 10g, Polygonum multiflorum 10g , donkey-hide gelatin 10g, licorice 10g.
经服本发明中药散剂40剂,治疗后复查心电图V4-6ST段恢复,T波较为直立平坦,治疗过程中未出现不良反应。After taking 40 doses of Chinese medicine powder of the present invention, after the treatment, the electrocardiogram V4-6ST segment was rechecked, and the T wave was relatively upright and flat, and adverse reactions did not occur in the treatment process.
以上各实例配方是发明人根据不同病人的病情及身体状况,运用的典型配方,经过配制,泡制成散剂,或丸剂,或汤剂,一般2剂服3天,饭后服用,一个月为一疗程,经90例冠心病(包括心绞痛、心肌梗死)患者试用观察,2-4个疗程均取得比较满意的效果,临床疗效观察,有效率达88.9%,经追访基本无复发。The formulas of the above examples are typical formulas used by the inventor according to the illness and physical conditions of different patients. After preparation, they are brewed into powders, pills, or decoctions. Generally, 2 doses are taken for 3 days, and they are taken after meals. After one course of treatment, 90 patients with coronary heart disease (including angina pectoris and myocardial infarction) were tested and observed. Satisfactory results were obtained in 2-4 courses of treatment. According to the clinical efficacy observation, the effective rate reached 88.9%, and there was basically no recurrence after follow-up.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101798634A CN101417086B (en) | 2008-12-03 | 2008-12-03 | Traditional Chinese medicine preparation for treating myocardial ischemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101798634A CN101417086B (en) | 2008-12-03 | 2008-12-03 | Traditional Chinese medicine preparation for treating myocardial ischemia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101417086A true CN101417086A (en) | 2009-04-29 |
CN101417086B CN101417086B (en) | 2011-03-09 |
Family
ID=40628212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101798634A Expired - Fee Related CN101417086B (en) | 2008-12-03 | 2008-12-03 | Traditional Chinese medicine preparation for treating myocardial ischemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101417086B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103212044A (en) * | 2013-04-08 | 2013-07-24 | 姜玉芝 | Traditional Chinese medicine composition for treating cardiovascular diseases |
CN103330911A (en) * | 2012-03-31 | 2013-10-02 | 李浩成 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
CN103385967A (en) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | Fleece-flower root-containing traditional Chinese medicine preparation and preparation method thereof |
CN104288709A (en) * | 2014-11-11 | 2015-01-21 | 邵明涛 | Chinese patent medicinal preparation for treating angina pectoris |
CN104306901A (en) * | 2014-11-11 | 2015-01-28 | 邵明涛 | Method for preparing traditional Chinese medicine preparation for angina pectoris |
EP3701961A4 (en) * | 2017-10-27 | 2021-07-21 | National Institute for Korean Medicine Development | Antithrombotic composition containing polygonum cuspidatum sieb. et zucc. and cinnamomum cassia blume |
-
2008
- 2008-12-03 CN CN2008101798634A patent/CN101417086B/en not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103330911A (en) * | 2012-03-31 | 2013-10-02 | 李浩成 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
CN103330911B (en) * | 2012-03-31 | 2014-12-17 | 韩笑峰 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
CN103212044A (en) * | 2013-04-08 | 2013-07-24 | 姜玉芝 | Traditional Chinese medicine composition for treating cardiovascular diseases |
CN103212044B (en) * | 2013-04-08 | 2015-04-01 | 周丽英 | Traditional Chinese medicine composition for treating cardiovascular diseases |
CN103385967A (en) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | Fleece-flower root-containing traditional Chinese medicine preparation and preparation method thereof |
CN104288709A (en) * | 2014-11-11 | 2015-01-21 | 邵明涛 | Chinese patent medicinal preparation for treating angina pectoris |
CN104306901A (en) * | 2014-11-11 | 2015-01-28 | 邵明涛 | Method for preparing traditional Chinese medicine preparation for angina pectoris |
EP3701961A4 (en) * | 2017-10-27 | 2021-07-21 | National Institute for Korean Medicine Development | Antithrombotic composition containing polygonum cuspidatum sieb. et zucc. and cinnamomum cassia blume |
Also Published As
Publication number | Publication date |
---|---|
CN101417086B (en) | 2011-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103251867B (en) | Chinese herbal compound medicine for treating diabetes mellitus and preparation method thereof | |
CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
CN101417086A (en) | Traditional Chinese medicine preparation for treating myocardial ischemia | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
CN104189811A (en) | Traditional Chinese medicine composition for treating postpartum fainting and preparation method thereof | |
CN104127756A (en) | Spleen invigorating anti-diarrheal paste | |
CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
CN104645249B (en) | One kind treats treating coronary heart disease and angina pectoris | |
CN103479969A (en) | Medicine for treating manic-depressive psychosis and preparation method thereof | |
CN103330837B (en) | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis | |
CN102416121B (en) | Application of medicinal composition in preparation of medicaments for treating gastric ulcer | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN101204494B (en) | Medicine for chronic enteritis | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
CN105999058A (en) | Spanishneedle herb lipid-lowering tablet | |
CN105535839A (en) | Traditional Chinese medicine tablets for treating colon cancer and preparation method thereof | |
CN105213905A (en) | A kind of Chinese medicine composition and application thereof preventing and treating postmenopausal osteoporosis | |
CN109078157A (en) | A kind of anti-tumor drug and preparation method thereof | |
CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN103110806A (en) | Medicine for treating climacteric syndrome | |
CN105125860A (en) | Preparation for effectively treating osteoporosis | |
CN105106913A (en) | Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type chronic colitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110309 Termination date: 20111203 |